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ABSTRACT
Context: Mouth dissolving film (MDF) is an innovative approach for systemic delivery of therapeutically/ medicinally active drug substance(s). 
Objective: The main objectives of Oral mouth dissolving films is to provide better bioavailability of drug, to have improved permeability, quick onset 
of action as well as improve patient compliance
Method: Preparation of films is similar to that of transdermal patch. Film when placed in mouth it get dissolve rapidly due to salivary fluid then it 
releases medicament(s), It will get absorbed within blood to show therapeutic action. 
Results: This overview provides information about formulation, technologies used in making mouth dissolving film formulations and evaluation tests 
carried out for the same. 
Conclusion: Mouth dissolving film formulations are innovative dosage form to improve the drug delivery, onset of action as well as improve patient compliance
Keywords: Mouth dissolving film, Permeability, Bioavailability, Salivary fluid.
INTRODUCTION
The mouth dissolving film (MDF) can be used for delivering a drug 
systemically to achieve the therapeutic or pharmacological effect. MDF 
formulations have improved systemic bioavailability as it escapes first 
pass effect [1,2]. Drug(s) which is to be delivered systemically, oral 
mucosa is a discerning site. This may be due to existence large surface 
area of the film which facilitates better absorption, pain avoidance also 
film can easily be swallowed without aqua [3]. New developments in 
technology have offered alternatives for oral dosage forms [4].
Orodispersible dosage forms have further advantages in patients who 
suffering from dysphagia (difficulty in swallowing), geriatric, and pediatric 
and also patients who undertaking anticancer therapy. Some available 
formulations like tablet, mouth dissolving films which are when placed in 
mouth they releases drug instantaneously with rapid onset of action [5-7].
IDEAL CHARACTERISTICS FOR MDF’S
The ideal characteristics of MDFs are as follows [8-10]:
•	 It	should	be	thin,	flexible,	and	easy	to	handle






•	 It	should	remain	physically	and	chemically	stable during its shelf life
•	 It	should	be	cost	effective	and	ease	of	commercial	production
•	 It	 should	 have	 low	 sensitivity	 to	 environmental/atmospheric	
conditions such as humidity and temp
•	 Size	of	 a	unit	 film	should	not	be	 too	bulky	 that	 it	will	 affect	 the	
patient’s compliance.
ADVANTAGES OF MDF’S











•	 Rapid	 disintegration	 of	 film	 gives	 quick	 onset	 of	 action;	 thus,	










•	 API’s	which	are	unstable at pH of the saliva cannot be designed in 
the	form	of	film.
•	 API’s	which	 can	 cause	 irritation	of	 the	 oral	mucosa	 cannot	 be	
administered.
Relationship	among	MDF	and	orally	disintegrating	tablet is shown in Table 1.
COMPOSITION OF MDF
The ingredients used in the formulation of MDF with its concentration 
are as shown in Table 2 [12].
API (drug)
The API from various classes that can be formulated into MDFs some 
examples areantiemetic, neuroleptics, antihypertensive, analgesics, 
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anxiolytics,	 diuretics,	 antitussives,	 antialzheimers,	 and	 parkinsonism	
agents [13-16].








Properties of polymer play a significant role in disintegration time of 
film. Several frequently used water-soluble polymers/film formers are 
hydroxypropylmethylcellulose, methylcellulose, pullulan, carboxymethyl 
cellulose, polyvinyl pyrrolidone, etc. An example of novel film former is 
polymerized	rosin	[22,23].






It avoids breakability of films. It should have compatibility with other 
ingredients. Some excipients are such as polyethylene glycol, phthalate, 
citrate derivatives, and castor oil [24].
Sweetening agents
Artificial or natural sweetening agents can be used in MDFs. Examples 
of some sweetening agents are sucrose, fructose, aspartame, sorbitol, 
acesulfame-K, and sucralose, etc.[25].
Saliva stimulating agent
These are useful to enhance the saliva creation in the mouth that gives 
quick disintegration. The examples of used acids are such as tartaric, 
lactic, malic, ascorbic, and citric [26].
Flavoring agents
Commonly used flavors are vanilla, coffee, cocoa, chocolate, citrus, etc., [27].
Coloring agents
Coloring agent like titanium dioxide is used in making films [28].
Surfactants
They	act	as	wetting,	dispersing,	or	solubilizing	agents,	few	examples	are	
poloxamer, sodium lauryl sulfate, and tweens [29].
METHODS USED IN PREPARATION OF MDF
Anyone of the following or a combination of one or more methods can 
be followed for making film formulation.
Solvent casting method
Films can be prepared using this method, the ingredients which are 
water-soluble are taken inaccurate quantity and are mixed well in 
beaker to make a clear solution. In other beaker containing suitable 
solvent add accurately weighed API and other ingredients. Then, both 
beakers containing formulation ingredients are mixed with stirring and 
finally cast into the Petri plate then allow it to dry for some period and 
cut	the	film	into	the	appropriate	size	[30,31].
Hot melt extrusion
In this method, all substances required to make films are taken together 
into its solid powder form. Then, this mixture is melted using extruder 
which having heaters into it and the melt is shaped into film. It is then 
cooled, cut, and packaged. This method has some advantages over the 
other methods such as minimum product wastage and better content 
uniformity [32].
Semisolid casting method
If films formulation contains some acid insoluble polymers, then this 
technique is appropriate [27]. The examples of such polymers are 
cellulose acetate butyrate cellulose acetate phthalate. In general, film 
former and acid insol. polymer used in ratio of 04:01 [33,34].
Rolling method
API containing suspension or solution is taken on a carrier and allowed 
to move onto it. Then keep to drying for some period and finally cut in 
appropriate dimensions [35].
Solid dispersion extrusion
When some immiscible substances are extruded with API in this 
methodology is followed. Solid dispersions are prepared, and then 
these are designed into thin films using dies [35].
PACKING AND STORAGE OF MDF
Blister card can be used as a packaging system for films. Single/unit 
packaging system is required. Widely used packaging- aluminum 
pouch, stored in a dry place [36].
EVALUATION PARAMETERS
The film produced by anyone of the above manufacturing method, 
then, they are subjected to evaluation. Evaluation is very crucial step 
to maintain inter- and intra-batch uniformity between films. Various 
evaluation parameters are as follows:
1.	 Organoleptic	 evaluation	 -	 prepared	 films	 are	 analyzed	 for	 its	
properties [37].




4. Weight variation test - the average weights are determined by 
weighing	each	 film,	 and	 then,	 the	average	weight	of	 the	 films	 is	
subtracted	from	the	individual	film	weight	[41].
5. Texture and physical appearance - texture is checked by simple touch 
and appearance to be determined simply with visual infection of 
films	[42].
6.	 Folding	endurance	-	the	film	again	and	again	folded	at	same	point	
until get breaks. F. endurance value is considered as number of times 
Table 1: Relationship Between MDF and ODT
MDF ODT
Greater durable than ODT A lesser durable as compared with 
MDF
Larger surface area gives better 
dissolution as this is thin film
Lesser dissolution due to less 
surface area as this is tablet
Suitable for drugs which need 
low dose
High dose can be incorporated
Patient compliance for film is 
more
Patient compliance is less than 
films
MDF: Mouth dissolving film, ODT: Orally disintegrating tablet






Hydrophilic polymer/film former 40–50
Saliva stimulating agent 02–06
Color 01
Surface active agent Quantity sufficient
API: Active pharmaceutical ingredient
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it is folded without breaking [42].
7. Tensile strength (TS) - it is calculated by Kumar et al. [43].
TS=Load	applied	at	failure×100/film	thickness×width	of	film.
8. Drug content uniformity - the assay method described in 
pharmacopeia is followed. It is determined by measuring the drug 
content	in	the	individual	film	[43].
9. Surface pH - the prepared formulation is taken in a glass plate for 30 
s containing water. The pH was noted after bringing the electrode 
of the pH meter in contact with the surface of the formulation and 
allowing equilibration for 1 min. The average of three determinations 





to 100–120°C until it attains constant weight and the difference in 
weight	gives	the	amount	of	moisture	present	in	the	film.	Moisture	
content can be calculated by following formula: % Moisture content 
= [(Initial weight-Final weight)×100/initial weight] [44].
11. Disintegration time - disintegration time of MDFs carried out using 
U.S.P. disintegration apparatus. The disintegration time should be 
about 30 s or less for mouth dissolving strips. Disintegration time 
will vary depending on the formulation ingredients but typically 
the	disintegration	range	from	5	to	30	s.	Although	there	is	no	official	
guidance	available	for	mouth	disintegrating	films		[45].
12. In vitro drug release - it is carried out by USP XXIII Type II apparatus 
in phosphate buffer pH 6.8 in 500 ml media and 0.1N HCl 500 ml 
media at the temperature is 37±0.5°C, and the rotation speed should 
be 50 rpm. The samples are withdrawn at various time intervals and 
should	analyze	spectrophotometrically	[45].
13. Percentage elongation - it is percentage ratio of the rise in length to 
the original length [46].
14. Young’s modulus (YM) - [46].
YM = (Force at corresponding strain/cross section area)×1/
(corresponding strain)
15. Stability studies - it is to be conducted as per the International 
Conference	on	Harmonization	guidelines	[46].
CONCLUSIONS
The MDF formulations are one of the innovative approaches in the 
pharmacy field in future it may become one of the promising dosage 
forms for treatment of disease or disorders. These novel formulations 
have improved and better patient compliance as well as acceptance, 
with enhanced safety and effectiveness than conventional formulations. 
MDF is having numerous advantages and leading to improved 
therapeutic response. At present, these formulations are available only 
for the management of some diseases so reflecting their importance 
likely other diseases can be managed by making film formulations using 
suitable API.
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